MARÍA TERESA
CABRERA CASTILLO
CATEDRÁTICA DE UNIVERSIDAD
MIGUEL ÁNGEL
LÓPEZ NEVOT
PROFESOR TITULAR DE UNIVERSIDAD
MIGUEL ÁNGEL LÓPEZ NEVOT-rekin lankidetzan egindako argitalpenak (21)
2021
-
HLA-DRB1 ∗ 16:01 and HLA-DQB1 ∗ 05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
Journal of Oncology, Vol. 2021
-
Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis
Journal of Oncology, Vol. 2021
2011
-
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Immunogenetics, Vol. 63, Núm. 2, pp. 65-71
2007
-
Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms
Tissue Antigens
-
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours
Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226
-
MHC Class I Antigens and Immune Surveillance in Transformed Cells
International Review of Cytology, Vol. 256, pp. 139-189
2006
-
LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas
Immunogenetics, Vol. 58, Núm. 7, pp. 503-510
2004
-
Distribution of HLA class I altered phenotypes in colorectal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21
Immunogenetics, Vol. 56, Núm. 4, pp. 244-253
2003
-
Analysis of HLA expression in human tumor tissues
Cancer Immunology, Immunotherapy, Vol. 52, Núm. 1, pp. 1-9
-
High frequency of HLA-B44 allelic losses in human solid tumors
Human Immunology, Vol. 64, Núm. 10, pp. 941-950
2002
-
Impaired surface antigen presentation in tumors: Implications for T cell-based immunotherapy
Seminars in Cancer Biology, Vol. 12, Núm. 1, pp. 15-24
-
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21
Cancer Immunology, Immunotherapy, Vol. 51, Núm. 7, pp. 389-396
2001
-
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-a*0301 allele in a prostate carcinoma cell line
Immunogenetics, Vol. 53, Núm. 7, pp. 606-610
-
Loss of HLA-B44 and type II altered HLA phenotype in human tumors
European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 327
2000
-
Molecular strategies to define HLA haplotype loss in microdissected tumor cells
Human Immunology, Vol. 61, Núm. 10, pp. 1001-1012
-
β2-Microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors
International Journal of Clinical and Laboratory Research, Vol. 30, Núm. 2, pp. 87-92
1998
-
Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides
Tissue Antigens, Vol. 52, Núm. 6, pp. 520-529
1995
-
Hla Class I Antigens in Human Tumors
Advances in Cancer Research, Vol. 67, Núm. C, pp. 155-195
1990
-
Class II HLA Antigen Expression in Familial Polyposis Coli is Related to the Degree of Dysplasia
Immunobiology, Vol. 180, Núm. 2-3, pp. 138-148
1987
-
Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: Relation with malignancy and invasiveness
Experimental and Clinical Immunogenetics, Vol. 4, Núm. 3, pp. 144-152